Hongxia Cai

819 total citations · 1 hit paper
17 papers, 488 citations indexed

About

Hongxia Cai is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Hongxia Cai has authored 17 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Hongxia Cai's work include RNA regulation and disease (3 papers), Computational Drug Discovery Methods (3 papers) and Genetics, Aging, and Longevity in Model Organisms (3 papers). Hongxia Cai is often cited by papers focused on RNA regulation and disease (3 papers), Computational Drug Discovery Methods (3 papers) and Genetics, Aging, and Longevity in Model Organisms (3 papers). Hongxia Cai collaborates with scholars based in China and United States. Hongxia Cai's co-authors include Yanhong Shi, Jonas Cerneckis, Guo‐Yuan Yang, Xiaoping Wang, Songlin Wang, Yongting Wang, Zhijun Zhang, Zhen Jiang, Zhihao Mu and Lei Wang and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Experimental Cell Research.

In The Last Decade

Hongxia Cai

15 papers receiving 484 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

2024 129 citations Jonas Cerneckis, Hongxia Cai et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongxia Cai China	12	198	86	81	63	62	17	488
Yiwu Dai China	12	174 0.9×	67 0.8×	84 1.0×	29 0.5×	68 1.1×	29	547
Gaoyu Cui China	11	162 0.8×	53 0.6×	40 0.5×	112 1.8×	65 1.0×	19	490
Zhenzhen Ma China	13	178 0.9×	73 0.8×	32 0.4×	43 0.7×	44 0.7×	46	527
Silvia Vanni Italy	15	210 1.1×	87 1.0×	45 0.6×	41 0.7×	40 0.6×	33	546
Xiaoyang Lu China	12	234 1.2×	73 0.8×	127 1.6×	86 1.4×	29 0.5×	21	531
Daniel von Bornstädt United States	7	130 0.7×	69 0.8×	29 0.4×	77 1.2×	42 0.7×	7	370
Lunxu Li China	15	122 0.6×	130 1.5×	45 0.6×	46 0.7×	70 1.1×	17	514
Eloïse Lemarchand United Kingdom	16	296 1.5×	182 2.1×	61 0.8×	98 1.6×	28 0.5×	25	709
Nadia Sadanandan United States	13	170 0.9×	80 0.9×	39 0.5×	79 1.3×	31 0.5×	23	380

Countries citing papers authored by Hongxia Cai

Since Specialization

Citations

This map shows the geographic impact of Hongxia Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Cai more than expected).

Fields of papers citing papers by Hongxia Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Cai. The network helps show where Hongxia Cai may publish in the future.

Co-authorship network of co-authors of Hongxia Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Cai. A scholar is included among the top collaborators of Hongxia Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Cai. Hongxia Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pan, Yan, Hongxia Cai, Yuxin Ran, et al.. (2025). Revealing 1,3-diphenylpropane’s coagulation toxicity via infomaxnet-based network toxicology and molecular simulations. Ecotoxicology and Environmental Safety. 303. 118834–118834.

Jing, Haiming, Yan Pan, Hongxia Cai, et al.. (2025). L-Theanine Extends the Lifespan of Caenorhabditis elegans by Reducing the End Products of Advanced Glycosylation. Foods. 14(2). 221–221. 1 indexed citations

Zhang, Nan, Hongxia Cai, Zhi‐Ru Li, et al.. (2025). HazChemNet: A Deep Learning Model for Hazardous Chemical Prediction. International Journal of Molecular Sciences. 26(19). 9288–9288.

Pan, Yan, Hongxia Cai, Wentao Xu, et al.. (2025). ElixirSeeker: A Machine Learning Framework Utilizing Fusion Molecular Fingerprints for the Discovery of Lifespan‐Extending Compounds. Aging Cell. 24(8). e70116–e70116. 1 indexed citations

Pan, Yan, Hongxia Cai, Dan Wu, et al.. (2024). WormCNN-Assisted Establishment and Analysis of Glycation Stress Models in C. elegans: Insights into Disease and Healthy Aging. International Journal of Molecular Sciences. 25(17). 9675–9675. 4 indexed citations

Cerneckis, Jonas, Hongxia Cai, & Yanhong Shi. (2024). Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal Transduction and Targeted Therapy. 9(1). 112–112. 129 indexed citations breakdown →

Wang, Songlin, Fang Yang, Hongxia Cai, et al.. (2022). LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease. Experimental Cell Research. 417(1). 113132–113132. 22 indexed citations

Cai, Hongxia, et al.. (2022). ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson’s disease. Hepatology. 76(4). 1046–1057. 28 indexed citations

Cai, Hongxia, Xiaoping Wang, & Guo‐Yuan Yang. (2021). Sleep Disorders in Stroke: An Update on Management. Aging and Disease. 12(2). 570–570. 69 indexed citations

10.

Li, Yu, Lin Gong, Chengrui An, et al.. (2021). Structural, functional and molecular pathogenesis of pelvic organ prolapse in patient and Loxl1 deficient mice. Aging. 13(24). 25886–25902. 16 indexed citations

11.

Wang, Songlin, et al.. (2020). NEAT1 Decreasing Suppresses Parkinson’s Disease Progression via Acting as miR-1301-3p Sponge. Journal of Molecular Neuroscience. 71(2). 369–378. 27 indexed citations

12.

Xu, Gang, Zuowei Duan, Hongxia Cai, et al.. (2020). Sustained expression of MCP‐1 induced low wall shear stress loading in conjunction with turbulent flow on endothelial cells of intracranial aneurysm. Journal of Cellular and Molecular Medicine. 25(1). 110–119. 12 indexed citations

13.

Cai, Hongxia, Bingbing Wu, Yu Li, et al.. (2019). Local Delivery of Silk-Cellulose Incorporated with Stromal Cell-Derived Factor-1α Functionally Improves the Uterus Repair. Tissue Engineering Part A. 25(21-22). 1514–1526. 20 indexed citations

14.

Wang, Songlin, et al.. (2019). MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson's disease mouse model. Journal of Cellular Physiology. 234(12). 23379–23387. 65 indexed citations

15.

Cai, Hongxia, Yuanyuan Ma, Lu Jiang, et al.. (2017). Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery via Glial Scar Degradation and Angiogenesis in Delayed Stroke. Molecular Therapy. 25(6). 1448–1459. 58 indexed citations

16.

Cai, Hongxia, Zhihao Mu, Zhen Jiang, et al.. (2015). Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia. Neuroscience Bulletin. 31(5). 550–560. 20 indexed citations

17.

Cai, Hongxia, Zhijun Zhang, & Guo‐Yuan Yang. (2014). Preconditioned Stem Cells: A Promising Strategy for Cell-Based Ischemic Stroke Therapy. Current Drug Targets. 15(8). 771–779. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact